Drug Shortage Report for AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN

Last updated on 2023-10-19 History
Report ID 192068
Drug Identification Number 02470780
Brand name AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
Common or Proper name AA-LANSOPRAZOLE-AMOXICILLIN-CLARITHROMYCIN
Company Name AA PHARMA INC
Market Status MARKETED
Active Ingredient(s) CLARITHROMYCIN AMOXICILLIN LANSOPRAZOLE
Strength(s) 500MG 500MG 30MG
Dosage form(s) TABLET CAPSULE KIT CAPSULE (DELAYED RELEASE)
Route of administration ORAL ORAL
Packaging size 56BLS
ATC code A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2023-05-08
Actual start date
Estimated end date 2023-10-19
Actual end date 2023-10-18
Shortage status Resolved
Updated date 2023-10-19
Company comments Stock available with expiry date Oct-31, 2023
Health Canada comments
Tier 3 Status No
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-10-19 English Compare
v11 2023-10-18 French Compare
v10 2023-10-18 English Compare
v9 2023-09-27 French Compare
v8 2023-09-27 English Compare
v7 2023-09-22 French Compare
v6 2023-09-22 English Compare
v5 2023-09-13 French Compare
v4 2023-09-13 English Compare
v3 2023-05-09 English Compare
v2 2023-05-08 French Compare
v1 2023-05-08 English Compare

Showing 1 to 12 of 12